Literature DB >> 31155508

Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons.

Guillermo Banuelos-Sanchez1, Laura Sanchez2, Maria Benitez-Guijarro2, Valentin Sanchez-Carnerero2, Carmen Salvador-Palomeque2, Pablo Tristan-Ramos3, Meriem Benkaddour-Boumzaouad2, Santiago Morell2, Jose L Garcia-Puche2, Sara R Heras3, Francisco Franco-Montalban1, Juan A Tamayo4, Jose L Garcia-Perez5.   

Abstract

Retrotransposons are a type of transposable element (TE) that have amplified to astonishing numbers in mammalian genomes, comprising more than a third of the human and mouse genomes. Long interspersed element class 1 (LINE-1 or L1) retrotransposons are abundant and currently active retroelements in the human and mouse genomes. Similarly, long terminal repeat (LTR)-containing retrotransposons are abundant in both genomes, although only active in mice. LTR- and LINE-1-retroelements use different mechanisms for retrotransposition, although both involve the reverse transcription of an intermediate retroelement-derived RNA. Retrotransposon activity continues to effect the germline and somatic genomes, generating interindividual variability over evolution and potentially influencing cancer and brain physiology, respectively. However, relatively little is known about the functional consequences of retrotransposition. In this study, we have synthesized and characterized reverse transcriptase inhibitors specific for mammalian LINE-1 retrotransposons, which might help deciphering the functional impact of retrotransposition in vivo.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  LINE-1; LTR-retrotransposon; brain genomic mosaicism; cancer; nucleoside analog; retrotransposition; reverse transcriptase

Year:  2019        PMID: 31155508     DOI: 10.1016/j.chembiol.2019.04.010

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  8 in total

1.  Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection.

Authors:  Eileen P Scully; Bryan D Bryson
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

2.  A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique.

Authors:  Yanni Kou; Shujie Wang; Yanjie Ma; Ning Zhang; Zixiong Zhang; Qian Liu; Yang Mao; Rui Zhou; Dongrong Yi; Ling Ma; Yongxin Zhang; Quanjie Li; Jing Wang; Jinhui Wang; Xile Zhou; Chunnian He; Jiwei Ding; Shan Cen; Xiaoyu Li
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 3.  Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing.

Authors:  Francesc X Ruiz; Anthony Hoang; Christopher R Dilmore; Jeffrey J DeStefano; Eddy Arnold
Journal:  Drug Discov Today       Date:  2022-02-23       Impact factor: 8.369

Review 4.  A potential new mechanism for pregnancy loss: considering the role of LINE-1 retrotransposons in early spontaneous miscarriage.

Authors:  Chao Lou; John L Goodier; Rong Qiang
Journal:  Reprod Biol Endocrinol       Date:  2020-01-21       Impact factor: 5.211

5.  The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition.

Authors:  Pablo Tristán-Ramos; Alejandro Rubio-Roldan; Guillermo Peris; Laura Sánchez; Suyapa Amador-Cubero; Sebastien Viollet; Gael Cristofari; Sara R Heras
Journal:  Nat Commun       Date:  2020-11-11       Impact factor: 14.919

Review 6.  Retrotransposons as a Source of DNA Damage in Neurodegeneration.

Authors:  Eugenie Peze-Heidsieck; Tom Bonnifet; Rania Znaidi; Camille Ravel-Godreuil; Olivia Massiani-Beaudoin; Rajiv L Joshi; Julia Fuchs
Journal:  Front Aging Neurosci       Date:  2022-01-04       Impact factor: 5.750

Review 7.  The Interplay Among HIV, LINE-1, and the Interferon Signaling System.

Authors:  Xu Zhao; Yifei Zhao; Juan Du; Pujun Gao; Ke Zhao
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

8.  Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota.

Authors:  Djalma S Lima-Junior; Siddharth R Krishnamurthy; Nicolas Bouladoux; Nicholas Collins; Seong-Ji Han; Erin Y Chen; Michael G Constantinides; Verena M Link; Ai Ing Lim; Michel Enamorado; Christophe Cataisson; Louis Gil; Indira Rao; Taylor K Farley; Galina Koroleva; Jan Attig; Stuart H Yuspa; Michael A Fischbach; George Kassiotis; Yasmine Belkaid
Journal:  Cell       Date:  2021-06-23       Impact factor: 41.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.